DexCom, Inc. vs First Trust Cloud Computing ETF — how do they compare? DexCom, Inc. trades at $77.79 (market cap $28.06B), while First Trust Cloud Computing ETF trades at $136.36. Which is the better fit depends on your goals.
| DXCM | SKYY | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | — |
52-Week High | $89.53 | $155.17 |
52-Week Low | $54.84 | $104.16 |
Enterprise Value | $27.03B | — |
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
First Trust Cloud Computing ETF (SKYY) trades at $137.24, down 1.49% today, with a bullish technical signal driven by moving averages. The ETF provides diversified exposure to the cloud computing sector, which is benefiting from enterprise digital transformation and AI adoption. Recent news highlights continued investor interest in technology ETFs, with SKYY being a prominent option for broad market access.
Outlook remains positive due to structural growth in cloud services, though risks include sector volatility and competitive pressures. Analyst sentiment is generally favorable, emphasizing long-term growth potential from AI and hybrid cloud trends. Investors should weigh sector momentum against valuation concerns in a high-interest-rate environment.
Trailing returns across standard periods
Latest headlines on both assets
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →The fund will normally invest at least 90% of its net assets (including investment borrowings) in the common stocks and depositary receipts that comprise the index. The index is designed to track the performance of companies involved in the cloud computing industry.
Read more on SKYY →